| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $59.54B | -11.4% |
| Cost of Revenue | $54.70B | -13.9% |
| Gross Profit | $4.84B | +31.6% |
| R&D Expense | $35.0M | +6.1% |
| SG&A Expense | $1.72B | +25.3% |
| Interest Expense | $516.0M | +28.0% |
| Pre-tax Income | $3.05B | +47.7% |
| Income Tax | $714.0M | +84.0% |
| Net Income | $2.24B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.60B | +135.7% |
| Short-term Investments | $105.0M | -11.8% |
| Accounts Receivable | $2.59B | -8.4% |
| Inventory | $7.11B | -15.5% |
| Current Assets | $16.35B | -2.4% |
| Total Assets | $25.37B | +3.2% |
| Current Liabilities | $7.69B | -19.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.31B | +159.6% |
| Capital Expenditures | $1.12B | +102.2% |
| Investing Cash Flow | -$1.01B | -115.5% |
| Financing Cash Flow | -$856.0M | -11.3% |
| Free Cash Flow | $2.19B | +135.8% |
| +39.3% |
| EPS (Basic) | $15.07 | +39.2% |
| EPS (Diluted) | $14.87 | +41.5% |
| Long-term Debt |
| $4.08B |
| -0.5% |
| Stockholders' Equity | $10.85B | +17.6% |